Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Current Protocols in Cytometry|April 4, 2017
Method for DNA Ploidy Analysis Along with Immunophenotyping for Rare Populations in a Sample using FxCycle VioletPrashant Tembhare, Yajamanam Badrinath, Sitaram Ghogale, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 17, 2015
A novel and easy FxCycle™ violet based flow cytometric method for simultaneous assessment of DNA ploidy and six-color immunophenotypingPrashant Tembhare, Yajamanam Badrinath, Sitaram Ghogale, et al.
Cytometry. Part B, Clinical Cytometry|March 29, 2016
CD19 negative precursor B acute lymphoblastic leukemia (B-ALL)-Immunophenotypic challenges in diagnosis and monitoring: A study of three casesKiran Ghodke, Asma Bibi, Nikhil Rabade, et al.
Cytometry. Part B, Clinical Cytometry|January 10, 2018
Evaluation of CD229 as a new alternative plasma cell gating marker in the flow cytometric immunophenotyping of monoclonal gammopathiesPrashant R Tembhare, Sitaram Ghogale, Wilma Tauro, et al.
Biochemia Medica|October 18, 2021
Improved protocol for plasma microRNA extraction and comparison of commercial kitsHarshini Sriram, Twinkle Khanka, Shweta Kedia, et al.
Indian Journal of Pathology & Microbiology|April 14, 2012
Morphological spectrum of leukemic mantle cell lymphomaKhaliqur Rahman, P G Subramanian, Pratibha Amare Kadam, et al.
Cytometry. Part B, Clinical Cytometry|August 2, 2020
Mast cell differentiation of leukemic blasts in diverse myeloid neoplasms: A potential pre-myelomastocytic leukemia conditionDevasis Panda, Gaurav Chatterjee, Twinkle Khanka, et al.
Cytometry. Part B, Clinical Cytometry|September 1, 2020
Utility of CD36 as a novel addition to the immunophenotypic signature of RAM-phenotype acute myeloid leukemia and study of its clinicopathological characteristicsDevasis Panda, Gaurav Chatterjee, Rohan Sardana, et al.
Cytometry. Part B, Clinical Cytometry|January 17, 2020
CD304/neuropilin-1 is a very useful and dependable marker for the measurable residual disease assessment of B-cell precursor acute lymphoblastic leukemiaPratyusha Gudapati, Twinkle Khanka, Gaurav Chatterjee, et al.
Pageof 3